BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Zhou MH, Ye MF, Zhang ZX, Tao F, Zhang Y. Cytokine release syndrome triggered by programmed death 1 blockade (sintilimab) therapy in a psoriasis patient: A case report. World J Clin Cases 2024; 12(18): 3555-3560 [PMID: 38983424 DOI: 10.12998/wjcc.v12.i18.3555]
URL: https://www.wjgnet.com/2307-8960/full/v12/i18/3555.htm
Number Citing Articles
1
Qiong Jin, Qinglei Fu, Bifeng Fei. Immune checkpoint inhibitors-related cytokine storm syndrome: a systematic review of characteristics, treatment, and outcomesFrontiers in Immunology 2026; 17 doi: 10.3389/fimmu.2026.1860219
2
Po-Chin Chao, Akiko Karakawa, Masahiro Hosonuma, Yuki Azetsu, Shogo Kamikawa, Aoi Oshio, Masahiro Chatani, Tatsuo Shirota, Masamichi Takami. Effects of anti-RANKL and anti-PD-1 antibodies on cancer-induced osteolysis in miceJournal of Oral Biosciences 2025; 67(3) doi: 10.1016/j.job.2025.100682
3
Mahesh Kumar Posa, Jyoti Singh, Sadia Parveen, Subhranshu Panda. CAR T- cell therapy: A promising novel approach for treatment of cancerCancer Treatment and Research Communications 2026; 47 doi: 10.1016/j.ctarc.2026.101125
4
Ming Li, Chen Li, Zhi-Min Lin, Yu-Wei Wang, Di Jin. Medical dilemma: Programmed death 1 blockade (sintilimab) therapy in patients suffering from tumours combined with psoriasisWorld Journal of Cardiology 2024; 16(9): 546-549 doi: 10.4330/wjc.v16.i9.546
5
Saurabh Upadhyay, Kirti Upmanyu, Moustafa T. Gabr. Designing immunity with cytokines: A logic-based framework for programmable CAR therapiesCytokine & Growth Factor Reviews 2025; 86 doi: 10.1016/j.cytogfr.2025.09.004
6
SintilimabReactions Weekly 2024; 2017(1) doi: 10.1007/s40278-024-63429-3
7
Lenin Pavón, Ana Fragozo, José Luis Maldonado-García. Cytokine release syndrome induced by anti-programmed death-1 treatment in a psoriasis patient: A dark side of immune checkpoint inhibitorsWorld Journal of Clinical Cases 2024; 12(35): 6782-6790 doi: 10.12998/wjcc.v12.i35.6782